Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep EEG in Children
NCT02195661Phase 3Completed
- Sponsor
- University of Cape Town
- Start
- Apr 2014
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
Phase 3, open-label trial (2 arms), sponsored by University of Cape Town. Primary endpoint: Efficacy of melatonin to induce sleep for EEG studies at 6 months. Started Apr 2014; status: completed.
Beyond the preview
Go deeper on NCT02195661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02195661.